Correction: H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis.

Correction: H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis.

Bibliographic Details
Main Authors:	Hélène Blasco, Philippe Corcia, Caroline Moreau, Ségolène Veau, Clémentine Fournier, Patrick Vourc'h, Patrick Emond, Paul Gordon, Pierre-François Pradat, Julien Praline, David Devos, Lydie Nadal-Desbarats, Christian R. Andres
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC2982987

Similar Items

1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis.
by: Hélène Blasco, et al.
Published: (2010-01-01)

Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis
by: Hugo Alarcan, et al.
Published: (2021-05-01)

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis
by: Débora Lanznaster, et al.
Published: (2020-05-01)

Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Amyotrophic Lateral Sclerosis
by: Camille Cotet, et al.
Published: (2023-11-01)

The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosis
by: Yara Al Ojaimi, et al.
Published: (2024-07-01)

The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls
by: Camille Petillon, et al.
Published: (2019-01-01)

Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
by: Débora Lanznaster, et al.
Published: (2020-04-01)

Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
by: Hugo Alarcan, et al.
Published: (2023-07-01)

Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis
by: Débora Lanznaster, et al.
Published: (2022-06-01)

Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosis
by: Hugo Alarcan, et al.
Published: (2022-10-01)

Optimization of Sample Preparation for Metabolomics Exploration of Urine, Feces, Blood and Saliva in Humans Using Combined NMR and UHPLC-HRMS Platforms
by: Cécile Martias, et al.
Published: (2021-07-01)

Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation
by: Audrey Dangoumau, et al.
Published: (2021-02-01)

TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis
by: Débora Lanznaster, et al.
Published: (2019-12-01)

First Metabolomic Signature of Blood-Brain Barrier Opening Induced by Microbubble-Assisted Ultrasound
by: Antoine Presset, et al.
Published: (2022-06-01)

Analytical Methodology for a Metabolome Atlas of Goat’s Plasma, Milk and Feces Using <sup>1</sup>H-NMR and UHPLC-HRMS
by: Cécile Martias, et al.
Published: (2021-10-01)

Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on <i>HECW1</i> Encoding the E3 Ligase NEDL1
by: Shanez Haouari, et al.
Published: (2023-01-01)

Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells
by: Rudolf Hergesheimer, et al.
Published: (2020-09-01)

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS
by: Débora Lanznaster, et al.
Published: (2018-12-01)

Correction: 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
Published: (2010-01-01)

SHR/NCrl rats as a model of ADHD can be discriminated from controls based on their brain, blood, or urine metabolomes
by: Camille Dupuy, et al.
Published: (2021-04-01)

Contribution of the dihydropyrimidinase-like proteins family in synaptic physiology and in neurodevelopmental disorders
by: Florence Desprez, et al.
Published: (2023-04-01)

The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration
by: Shanez Haouari, et al.
Published: (2022-03-01)

Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?
by: Hugo Alarcan, et al.
Published: (2022-06-01)

CSF chitinase proteins in amyotrophic lateral sclerosis
by: Thompson, A, et al.
Published: (2019)

Molecular imaging of microglial activation in amyotrophic lateral sclerosis.
by: Philippe Corcia, et al.
Published: (2012-01-01)

Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis
by: Débora Lanznaster, et al.
Published: (2020-07-01)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
by: Corcia P, et al.
Published: (2012-08-01)

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression.
by: Hélène Blasco, et al.
Published: (2018-01-01)

Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions
by: Vincent Grollemund, et al.
Published: (2019-02-01)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
by: Gray, E, et al.
Published: (2020)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
by: Elizabeth Gray, et al.
Published: (2020-08-01)

Rarity of microbial species: In search of reliable associations.
by: Arnaud Cougoul, et al.
Published: (2019-01-01)

Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis.
by: Alexandre Henriques, et al.
Published: (2015-01-01)

Global alterations to the choroid plexus blood-CSF barrier in amyotrophic lateral sclerosis
by: J. Saul, et al.
Published: (2020-06-01)

Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis
by: Siw Johannesen, et al.
Published: (2021-03-01)

The importance of multiparasitism: examining the consequences of co-infections for human and animal health
by: Elise Vaumourin, et al.
Published: (2015-10-01)

Les maladies émergentes : un défi pour le développement durable des productions animales
by: J. BARNOUIN, et al.
Published: (2004-10-01)

Including citizens through co-design in a participatory research project to explore innovative agro-food systems: the case of future dairy livestock systems
by: Philippine Coeugnet, et al.
Published: (2023-06-01)

Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient
by: Mickael Vourc’h, et al.
Published: (2018-06-01)

CSF concentrations of cAMP and cGMP are lower in patients with Creutzfeldt-Jakob disease but not Parkinson's disease and amyotrophic lateral sclerosis.
by: Patrick Oeckl, et al.
Published: (2012-01-01)